Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[OCT-angiography in glaucoma diagnosis - A multicenter case-control study].

Journal francais d'ophtalmologie·2025
Same author

Etiology, presentation and management of urinary tract infections in multiple sclerosis patients: A review of the current literature.

Urologia·2024
Same author

Methylation Analysis of Urinary Sample in Non-Muscle-Invasive Bladder Carcinoma: Frequency and Management of Invalid Result.

Biomedicines·2023
Same author

Male infertility and urological tumors: Pathogenesis and therapeutical implications.

Urologia·2023
Same author

Prevalence and management of antivitamin K overdose in a hospital setting.

Journal de medecine vasculaire·2021
Same author

The clinical use of statistical permutation test methodology: a tool for identifying predictive variables of outcome.

Urologia internationalis·2014

Related Experiment Video

Updated: Jun 6, 2026

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

[Transitional cell carcinoma of the prostate].

P F Bassi, R Falabella, E Sacco

    Urologia
    |November 19, 2010
    PubMed
    Summary

    Transitional cell carcinoma of the prostate (TCCP) is increasingly recognized as part of urothelial disease. Early diagnosis and appropriate treatment, ranging from conservative measures to radical cystectomy, are crucial for managing TCCP based on invasion depth.

    Area of Science:

    • Uro-oncology
    • Pathology

    Context:

    • Transitional cell carcinoma of the prostate (TCCP) is an increasingly recognized entity.
    • TCCP is associated with the broader category of pan-urothelial disease.
    • Urologists must consider the prostate in bladder cancer management.

    Purpose:

    • To highlight the diagnostic and management considerations for TCCP.
    • To emphasize the relationship between TCCP and bladder cancer.
    • To discuss treatment strategies based on TCCP invasiveness.

    Summary:

    • TCCP incidence is rising due to increased awareness.
    • Secondary TCCP occurs with bladder cancer; primary TCCP is rare.
    • Prognosis and treatment depend on the degree of prostate invasion.
    • Non-invasive TCCP is managed conservatively (TUR +/- BCG).

    More Related Videos

    Evaluating the Differentiation Capacity of Mouse Prostate Epithelial Cells Using Organoid Culture
    10:38

    Evaluating the Differentiation Capacity of Mouse Prostate Epithelial Cells Using Organoid Culture

    Published on: November 22, 2019

    Intra-Cardiac Injection of Human Prostate Cancer Cells to Create a Bone Metastasis Xenograft Mouse Model
    06:32

    Intra-Cardiac Injection of Human Prostate Cancer Cells to Create a Bone Metastasis Xenograft Mouse Model

    Published on: November 4, 2022

    Related Experiment Videos

    Last Updated: Jun 6, 2026

    A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
    07:25

    A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

    Published on: March 6, 2018

    Evaluating the Differentiation Capacity of Mouse Prostate Epithelial Cells Using Organoid Culture
    10:38

    Evaluating the Differentiation Capacity of Mouse Prostate Epithelial Cells Using Organoid Culture

    Published on: November 22, 2019

    Intra-Cardiac Injection of Human Prostate Cancer Cells to Create a Bone Metastasis Xenograft Mouse Model
    06:32

    Intra-Cardiac Injection of Human Prostate Cancer Cells to Create a Bone Metastasis Xenograft Mouse Model

    Published on: November 4, 2022

  • Stromal invasive TCCP requires aggressive treatment (radical cystectomy).
  • TCCP can complicate urinary diversion decisions post-cystectomy.

    • Impact:

    • Improved recognition of TCCP within uro-oncology.
    • Guidance for urologists in managing TCCP and associated urothelial cancers.
    • Informed treatment decisions based on TCCP staging and invasion.
    • Potential for better patient outcomes through tailored therapeutic approaches.